VASCEPA® (icosapent ethyl) is available at a lower cost than generic icosapent ethyl for most patients
Commercially insured patients can pay $9 or less for branded VASCEPA using the VASCEPA Savings Card
VASCEPA is the exclusive IPE for many nationally insured lives
Certain plans lack coverage for generic icosapent ethyl and may block it altogether
Even eligible, commercially insured patients paying a generic tier copay may have their prescription cost reduced by using the VASCEPA Savings Card
If generic icosapent ethyl is rejected, rerun the patient's claim using these steps:
• Step 1: Check if branded VASCEPA is being filled—if not, override the system with your patient's permission
• Step 2: Check if the savings program is being utilized
• For further savings, call the patient’s provider and ask if they can prescribe a 90-day supply of VASCEPA
Eligible, commercially insured patients can pay as little as $9 for a 90-day supply with the VASCEPA Savings Card. Subject to eligibility. Restrictions apply.
You can download the universal VASCEPA Savings Card at vascepahcp.com/savings.
Amarin Corporation is focused on a BOLD vision to stop heart disease from being a leading cause of death. Our lead commercial product, VASCEPA® (icosapent ethyl), creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally
